Chemicals giant Mitsubishi Chemical Group has announced its decision to end all of its activities with Medicago Inc., a Quebec-headquartered company.
The group announced their decision in a statement on Friday morning, local time in Japan.
This judgment affects the activities of Medicago Inc., Medicago R&D and Medicago USA Inc.
As the sole shareholder, the Group has decided not to continue its investment in Medicago and to proceed with the liquidation of the company and its operations in Canada and the United States.
Medicago is a Canadian biopharmaceutical company focused on the discovery and development of novel vaccines using plant-based virus-like particle (VLP) technology.
Do you have any information about this story that you would like to share with us?
Do you have a scoop that might be of interest to our readers?